1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline has been researched along with Muscle Rigidity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antkiewicz-Michaluk, L; RomaĆska, I; Wasik, A | 1 |
Antkiewicz-Michaluk, L; Lorenc-Koci, E; Michaluk, J; Mokrosz, M; Ohta, S; Romanska, I; Vetulani, J | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and Muscle Rigidity
Article | Year |
---|---|
1-Benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous parkinsonism-inducing toxin, strongly potentiates MAO-dependent dopamine oxidation and impairs dopamine release: ex vivo and in vivo neurochemical studies.
Topics: Analysis of Variance; Animals; Basal Ganglia; Brain Chemistry; Dopamine; Drug Administration Schedule; Male; Microdialysis; Motor Activity; Muscle Rigidity; Neurotoxins; Rats; Rats, Wistar; Tetrahydroisoquinolines; Time Factors | 2009 |
Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Homovanillic Acid; Isoquinolines; Male; Motor Activity; Muscle Rigidity; Nucleus Accumbens; Rats; Rats, Wistar; Substantia Nigra; Tetrahydroisoquinolines | 2001 |